Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole

YILMAZ M., ÇELİK A. F., MERT A.

Journal of Infection and Chemotherapy, cilt.13, sa.2, ss.122-123, 2007 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 2
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1007/s10156-007-0505-z
  • Dergi Adı: Journal of Infection and Chemotherapy
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.122-123
  • Anahtar Kelimeler: Bacteremia, Desensitization, Stenotrophomonas maltophilia, Trimethoprim-sulfamethoxazole
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Stenotrophomonas maltophilia has emerged as an important cause of morbidity and mortality in hospitalized patients. Because trimethoprim-sulfamethoxazole (TMP-SMX) remains the most effective drug for the treatment of S. maltophilia infections, desensitization should be considered in patients with hypersensitivity to TMP-SMX. © 2007 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.